Viewing Study NCT00134251

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2025-12-27 @ 12:38 AM
Study NCT ID: NCT00134251
Status: COMPLETED
Last Update Posted: 2009-01-30
First Post: 2005-08-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Ascending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's Disease
Sponsor: Solvay Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Parkinson's Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Parkinson's disease View
None adjunctive to L-dopa therapy View
None Advanced stage Parkinson's disease View